1. |
中華醫學會肝病學分會、傳染病學分會. 慢性乙型肝炎防治指南[J]. 中華肝臟病雜志, 2005, 13(12): 881-891.
|
2. |
中華醫學會傳染病與寄生蟲病學分會、肝病學分會. 病毒性肝炎防治方案[J]. 中華肝臟病雜志, 2000, 8(6): 342-329.
|
3. |
Ganem D, Prince AM. Hepatitis B virus infection-natural history and clinical consequences[J]. N Engl J Med, 2004, 350(11): 1118-1129.
|
4. |
World Health Organization. Hepatitis B (Revised August 2008)(2010-12-09)[2011-09-24].[EB/OL]. http://www.who.int/medicacentre/fact-sheets/fs204/en/.
|
5. |
European Association For The Study Of The Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B[J]. J Hepatol, 2009, 50 (2): 227-242.
|
6. |
Liu Y, Wang CM, Cheng J, et al. Hepatitis B virus in tenofovir-naive Chinese patients with chronic hepatitis B contains no mutation of rtA194T conferring a reduced tenofovir susceptibility[J]. Chin Med J (Engl) 2009,122 (13): 1585-1586.
|
7. |
Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures[J]. J Viral Hepatitis, 2004, 11 (2): 97-107.
|
8. |
葉任高. 內科學[M]. 6版. 北京: 人民衛生出版社, 2003: 303.
|
9. |
戴萬亨. 中西醫臨床內科學[M]. 北京: 中國醫藥科技出版社, 2003: 39-41.
|
10. |
王伯祥. 慢性乙型肝炎中醫藥證治研究進展[J]. 世界中醫藥, 2007, 1(2): 61-62.
|
11. |
《中醫藥創新與發展》編委會. 中醫藥防治在重大傳染病的研究[M]. 成都:四川科學技術出版社, 2010: 105-240.
|